+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Dermatological Drugs Market Research Reports

VELSIPITY Sales Forecast and Market Size Analysis - 2034 - Product Thumbnail Image

VELSIPITY Sales Forecast and Market Size Analysis - 2034

  • Report
  • March 2026
  • 30 Pages
  • Global
From
From
Atopic Dermatitis - Competitive Landscape, 2026 - Product Thumbnail Image

Atopic Dermatitis - Competitive Landscape, 2026

  • Report
  • January 2026
  • 240 Pages
  • Global
From
From
From
From
From
From
From
SHR-0302 Sales Forecast, and Market Size Analysis - 2034 - Product Thumbnail Image

SHR-0302 Sales Forecast, and Market Size Analysis - 2034

  • Report
  • May 2026
  • 30 Pages
  • Global
From
TREMFYA Sales Forecast and Market Size Analysis - 2034 - Product Thumbnail Image

TREMFYA Sales Forecast and Market Size Analysis - 2034

  • Report
  • April 2026
  • 30 Pages
  • Global
From
From
From
From
From
From
From
From
Neurodermatitis Epidemiology Forecast 2026-2035 - Product Thumbnail Image

Neurodermatitis Epidemiology Forecast 2026-2035

  • Report
  • May 2026
  • 100 Pages
  • Global
From
Bullous Pemphigoid Epidemiology Forecast 2026-2035 - Product Thumbnail Image

Bullous Pemphigoid Epidemiology Forecast 2026-2035

  • Report
  • May 2026
  • 100 Pages
  • Global
From
Loading Indicator

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally. The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more